Articles dans des revues avec comité de lecture (53)
  1. 47. Montanelli, L., Delbaere, A., Di Carlo, C., Nappi, C., Smits, G., Vassart, G., & Costagliola, S. (2004). A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. The Journal of clinical endocrinology and metabolism, 89(4), 1255-1258. doi:10.1210/jc.2003-031910
  2. 48. Delbaere, A., Smits, G., Olatunbosun, O., Pierson, R., Vassart, G., & Costagliola, S. (2004). New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Human reproduction, 19(3), 486-489. doi:10.1093/humrep/deh124
  3. 49. Smits, G., Olatunbosun, O., Delbaere, A., Pierson, R., Vassart, G., & Costagliola, S. (2003). Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. The New England journal of medicine, 349(8), 760-766. doi:10.1056/NEJMoa030064
  4. 50. Smits, G., Campillo, M., Govaerts, C., Janssens, V., Richter, C., Vassart, G., Pardo, L., & Costagliola, S. (2003). Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO journal, 22(11), 2692-2703. doi:10.1093/emboj/cdg260
  5. 51. Smits, G., Govaerts, C., Nubourgh, I., Pardo, L., Vassart, G., & Costagliola, S. (2002). Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Molecular endocrinology, 16(4), 722-735.
  6. 52. Costagliola, S., Panneels, V., Bonomi, M., Koch, J., Many, M.-C., Smits, G., & Vassart, G. (2002). Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO journal, 21(4), 504-513. doi:10.1093/emboj/21.4.504
  7. 53. Smits, G., Parma, J., & Vassart, G. (2000). Peg3 and the conflict hypothesis. Science, 287(5456), 1167.
    8.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (2)
  8. 1. D'Alva, C. B., Serafini, P., Motta, E., Latronico, A. C., Mendonca, B. B., Daelemans, C., Smits, G., De Maertelaer, V., Costagliola, S., Englert, Y., Vassart, G., & Delbaere, A. (2005). Letter re: FSH receptor polymorphisms and iatrogenic ovarian hyperstimulation [1] (multiple letters). The Journal of clinical endocrinology and metabolism, 90(8), 4978-4979. doi:10.1210/jc.2005-0650
  9. 2. Daelemans, C., Smits, G., De Maertelaer, V., Costagliola, S., Englert, Y., Vassart, G., & Delbaere, A. (2005). Author’s response: Severity of iatrogenic ovarian hyperstimulation syndrome (OHSS) can be predicted by N680allele of FSH receptor. The Journal of clinical endocrinology and metabolism, 90, 4978-4979.
    10.   Participations à des congrès et colloques internationaux (31)
  10. 1. Gravel, B., Renaux, A., Papadimitriou, S., Smits, G., Nowé, A., & Lenaerts, T. (2024). Prioritization of variant combinations in whole exomes. Abstract session presented at European Conference on Computational Biology.(23: 16/09-20/09/2024: Turku, Finland)
  11. 2. Gravel, B., Papadimitriou, S., Nachtegael, C., De Baere, E., Loeys, B., Vikkula, M., Smits, G., & Lenaerts, T. (2023). The importance of good data quality and proper pathogenicity reporting in the medical genetics field: the case of oligogenic diseases. Abstract session presented at Genomics of Rare Disease(17: 24-26/04/2023: Wellcome Genome Campus, UK)
  12. 3. Nachtegael, C., Papadimitriou, S., Gravel, B., De Baere, E., Loeys, B., Vikkula, M., Smits, G., & Lenaerts, T. (2023). The importance of good data quality and proper pathogenicity reporting in the medical genetics field: the case of oligogenic diseases. Abstract session presented at Annual Biocuration Conference(16: 24-26/04/2023: Padua, Italie)
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>